Pharmacotherapeutic group
Gonadotropins

Recombinant humanized chorionic gonadotropin produced by recombinant DNA techniques

Indications:
Triggering ovulation and luteinization in anovulatory patients after stimulation of follicular growth.
Superovulation for assisted reproductive technologies.

250 mcg/vial
Registration status: UA/1175/01/01; expiry date: 14.05.2009
Dosage: 250 mcg/vial
Packaging: 1 vial with powder + 1 vial with solvent
Shelf-life (months): 24

250 mcg/0,5 ml
Registration status: UA/1175/02/01; expiry date: 15.12.2011
Dosage: 250 mcg/0,5 ml
Packaging: 1 pre-filled syringes
Shelf-life (months): 24 (t +2 - +8 C)